Mallinckrodt plc, a global specialty pharmaceutical company, today announced that it will report its second quarter 2025 financial results on Wednesday, August 6, 2025.

Mallinckrodt plc today announced that the Irish High Court has given the necessary ruling to enable its combination with Endo, Inc. (OTCQX: NDOI), advancing the companies' plan to merge in a stock and ...